Elevance Health, Inc. (NYSE:ELV) and other Blue Cross Blue Shield plans drew fresh attention this week as a long-running antitrust case enters the cash-distribution phase, with settlement checks slated to start going out in May 2026. The timing lands as affordability strains show up in enrollment behavior, with one in seven ACA enrollees skipping the first premium after enhanced subsidies ended and monthly costs jumped.
- ELV shares are trending up modestly. Track it now here.
Will The Settlement Impact Healthcare Costs?
USA Today reported that Blue Cross Blue Shield's $2.67 billion settlement fund follows a class action accusing more than 35 affiliated plans of restricting competition, which plaintiffs argued pushed premiums higher and narrowed choices. The companies denied wrongdoing and resolved the dispute without a final court verdict.
The settlement arrives as ACA affordability worsens after pandemic-era support rolled off in January. Data from insurers covering about 80% of ACA enrollment across 30 states showed roughly 14% of enrollees didn't pay January premiums, with some states at 25% or more.
A Wakely Consulting Group actuary, Michelle Anderson, called the early-year decline a "big drop," versus the mid-single-digit churn that is more typical.
How Enrollment Trends Reveal Consumer Strain
The expected average payout depends on how many people filed claims: about six million, implying roughly $333 per claim before any individual-specific adjustments. Only about $1.9 billion is expected to be available for claimants after legal fees and administrative costs.
Wakely projects ACA enrollment may fall 17% to 26% versus last year. ACA sign-ups were cited at 23 million in 2026, down from more than 24 million the year before.
In Arizona, Blue Cross Blue Shield of Arizona said it lost more than 30% of people who initially selected 2026 plans, with most losses tied to nonpayment, versus about 2% the prior year. A Gallup survey released in April found 61% of Americans worry "a great deal" about access and affordability in healthcare.
Senator Mark Kelly faulted the Trump administration and Republicans for allowing premiums to climb beyond what many families can handle. President Donald Trump has attacked the ACA and floated shifting federal support toward consumers instead of insurers.
What Investors Need To Know About ELV
For ELV investors, the settlement is not new, but distributions could put the Blue Cross Blue Shield brand back in headlines while consumers are sensitive to premium increases. The case dates back to 2013 and involved a broad set of Blue Cross Blue Shield plans rather than a single operator.
Eligibility is narrow: claimants needed to submit paperwork by Nov. 5, 2021, and anyone who missed that deadline won't receive a payment. The settlement covers individual and insured group members from Feb. 7, 2008 to Oct. 16, 2020, plus self-funded accounts from Sept. 1, 2015 to Oct. 16, 2020.
ELV Price Action: Elevance Health shares were up 2.48% at $371.75 at publication time on Wednesday, according to Benzinga Pro.
Image: Jonathan Weiss / Shutterstock
Login to comment